Shanghai Kingstar Winning Software Science and Technology Co., Ltd, a leading provider of digitalization risk control solutions for medical and commercial insurance, has reportedly raised RMB 300 million (USD 43.39 million) in a Series C financing round. The round was led by China Taiping Insurance Group Company’s healthcare funds, with participation from Cathay Capital, CEC Data, SND Group, and Ti Liang Investment. The funds will be allocated towards technology research and development, expansion into new business areas, and enhancement of the company’s business functions and properties.
Company Background and National Healthcare Security Administration (NHSA) Partnership
Founded in 2012, Kingstar Winning has established itself as a key player in the digital healthcare space. The company secured an exclusive bid for the National Healthcare Security Administration’s (NHSA) “fund operation and audit supervision system” and “medical security intelligent supervision system” in 2019, reinforcing its position in the industry. Kingstar Winning’s business footprint is extensive, covering over 1,400 hospitals across 70% of China, making it a significant contributor to the digitization of healthcare services in the country.
Expanding Digital Healthcare Services
With the proceeds from the Series C financing, Kingstar Winning is poised to further its mission of enhancing technology research and development, expanding its business into new areas, and improving its service offerings. The investment will also support the company’s ongoing efforts to complement and strengthen its business functions and properties, ensuring it remains at the forefront of digital healthcare solutions in China.-Fineline Info & Tech
